HCA Healthcare, Inc. $HCA Position Reduced by Atria Investments Inc

Atria Investments Inc decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,025 shares of the company’s stock after selling 1,242 shares during the period. Atria Investments Inc’s holdings in HCA Healthcare were worth $2,141,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the company. Clearstead Trust LLC lifted its position in shares of HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. raised its position in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the period. Twin Peaks Wealth Advisors LLC bought a new position in HCA Healthcare during the 2nd quarter worth $40,000. Compound Global Advisors LLC acquired a new position in shares of HCA Healthcare during the third quarter valued at $44,000. Finally, True Wealth Design LLC lifted its position in HCA Healthcare by 179.5% in the 3rd quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after purchasing an additional 70 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $534.53 on Wednesday. The firm has a market cap of $119.53 billion, a price-to-earnings ratio of 18.83, a P/E/G ratio of 1.66 and a beta of 1.36. The stock has a 50-day simple moving average of $484.82 and a 200-day simple moving average of $452.18. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $552.90.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the business earned $6.22 EPS. The firm’s revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

Analyst Ratings Changes

Several brokerages have recently issued reports on HCA. Truist Financial boosted their price objective on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Cantor Fitzgerald upped their price objective on shares of HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft increased their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Leerink Partners raised their target price on HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Finally, Robert W. Baird lifted their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $523.27.

Insider Activity

In related news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 13,520 shares of company stock valued at $6,894,067. 1.30% of the stock is owned by insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.